Penile primary melanoma: Analysis of 6 patients treated at Brazilian National Cancer Institute in the last eight years - Abstract

Purpose: To describe our experience in treating penile melanoma in 06 patients followed at our institution.

Materials and Methods: Between 2004 and 2012 six consecutive patients with penile melanoma were treated at our Institution. Stage of the disease was classified according to the 2002 AJCC pathologic system. Melanoma in situ (TIS) was diagnosed in one patient. One patient was staged as T1b, two patients as T2b and two patients as T4b. The clinical and pathological findings were evaluated. Immunohistochemical tests were performed for Melan-A, HNB-45, S-100 and C-KIT. All histological specimens were examined by the same pathologist (ABSS). The patients with Cis, stages T1b and one patient T2b underwent only local excision. One patient T2b underwent local excision and sentinel lymph node dissection. Two patients with melanoma stage T4b underwent partial penile amputation. One of these last patients had palpable inguinal lymph nodes at diagnosis and underwent bilateral inguinal lymphadenectomy and received systemic chemotherapy (dacarbazine, 30 cycles).

Results: Mean follow-up was 36.3 months. One patient, with stage T2b, died after 12 months due to disease recurrence with bilateral inguinal involvement. The patient who underwent chemotherapy progressed with lung metastases and died after 14 months of follow up. The disease-free survival at five years was 33.3%.

Conclusion: Penile melanoma is a disease with poor prognosis in most cases. Local excision or partial penile amputation may have effective control for stages T1 and T2 lesions. Patients who have clinically proven metastases died despite surgical and adjuvant chemotherapy.

Written by:
Bechara GR, Schwindt AB, Ornellas AA, da Silva DE, Lott FM, de Campos FS.   Are you the author?
Departments of Urology, Brazilian National Cancer Institute, Rio de Janeiro, RJ, Brazil.

Reference: Int Braz J Urol. 2013 Nov-Dec;39(6):823-31.
doi: 10.1590/S1677-5538.IBJU.2013.06.08


PubMed Abstract
PMID: 24456774

Go "Beyond the Abstract" - Read an article written by the authors for UroToday.com

UroToday.com Penile and Urethral Cancers Section